Come up with a name for your new list and we'll add to it:
Retrotope raised a round of funding on October 22, 2014. Investors include
Life Science Angels.
Retrotope has created a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. The unique mechanism of Retrotope's platform prevents cellular damage and r…